Evidence check: Glukose in the context of blood sugar

The question about glucose in the context of blood sugar is a classic example of combining biomarker and DNA analysis. A direct blood test (fasting glucose or HbA1c) is the gold standard for measuring current blood sugar levels. DNA tests, such as those offered by MyBody-X, can only identify genetic variants with small effects on fasting glucose – for example, rs10830963 in the MTNR1B gene (about 1.38 mg/dL increase per G allele). These effects come from GWAS studies (human observational data) and are not diagnostic. A value of 190 mg/dL LDL or elevated fasting glucose are clinical red flags requiring medical evaluation. Consumer tests often overstate the clinical relevance of such SNPs. The evidence for genetic prediction of blood sugar is moderate but insufficient for medical decisions. Safety note: Do not rely on a DNA test to rule out or diagnose diabetes. Combine blood tests with medical advice.